Biomarker time out

• The advancement of knowledge relies on scientific investigations. The timing between asking a question and data collection defines if a study is prospective or retrospective. Prospective studies look forward from a point in time, are less prone to bias and are considered superior to retrospective studies. This conceptual framework conflicts with the nature of biomarker research. New candidate biomarkers are discovered in a retrospective manner. There are neither resources nor time for prospective testing in all cases. Relevant sources for bias are not covered. Ethical questions arise through the time penalty of an overly dogmatic concept. The timing of sample collection can be separated from testing biomarkers. Therefore the moment of formulating a hypothesis may be after sample collection was completed. A conceptual framework permissive to asking research questions without the obligation to bow to the human concept of calendar time would simplify biomarker research, but will require new safeguards against bias.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

Biomarker study design

bias

multiple sclerosis

Alzheimer disease

Parkinson syndrome

traumatic

CEREBROSPINAL-FLUID

PARKINSONS-DISEASE

ALPHA-SYNUCLEIN

MULTIPLE-SCLEROSIS

ALZHEIMER-DISEASE

PROTEOMICS

UTILITY

CSF

Clinical Neurology

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)